Skip to main content

Advertisement

SpringerLink
Log in

Use of pharmacy refill data as a measure of antiretroviral adherence

  • Published:
Current HIV/AIDS Reports Aims and scope Submit manuscript

Abstract

Pharmacy refill adherence has become an increasingly important measure of adherence to antiretroviral medications. It offers a simple, inexpensive, and valid method for measuring adherence. Over the past year, there have been several published developments in the use of pharmacy refill data to measure adherence. Given the utility of this adherence measurement, it is likely that pharmacy refill will be the method of choice for measuring antiretroviral adherence in an increasing number of clinical and research settings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Steiner JF, Koepsell TD, Fihn SD, Inui TS: A general method of compliance assessment using centralized pharmacy records. Description and validation. Med Care 1988, 26:814–823.

    Article  PubMed  CAS  Google Scholar 

  2. Steiner JF, Prochazka AV: The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997, 50:105–116.

    Article  PubMed  CAS  Google Scholar 

  3. Low-Beer S, Yip B, O’shaughnessy MV, et al.: Adherence to triple therapy and viral load response. J Acquir Immune Defic Syndr 2000, 23:360–361.

    PubMed  CAS  Google Scholar 

  4. Grossberg R, Zhang Y, Gross R: A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. J Clin Epidemiol 2004, 57:1107–1110.

    Article  PubMed  Google Scholar 

  5. Wood E, Montaner JS, Yip B, et al.: Adherence to antiretroviral therapy and CD4 T-cell count responses among HIV-infected injection drug users. Antivir Ther 2004, 9:229–235.

    PubMed  CAS  Google Scholar 

  6. Wood E, Hogg RS, Yip B, et al.: The impact of adherence on CD4 cell count responses among HIV-infected patients. J Acquir Immune Defic Syndr 2004, 35:261–268.

    Article  PubMed  Google Scholar 

  7. Harrigan PR, Hogg RS, Dong WW, et al.: Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis 2005, 191:339–347.

    Article  PubMed  CAS  Google Scholar 

  8. Wood E, Hogg RS, Yip B, et al.: Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 × 10(9) cells/L. Ann Intern Med 2003, 139:810–816.

    PubMed  Google Scholar 

  9. Wood E, Montaner JS, Yip B, et al.: Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. CMAJ 2003, 169:656–661.

    PubMed  Google Scholar 

  10. Palepu A, Tyndall MW, Joy R, et al.: Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend 2006, 84:188–194.

    Article  PubMed  Google Scholar 

  11. Turner BJ, Laine C, Cosler L, Hauck WW: Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. J Gen Intern Med 2003, 18:248–257.

    Article  PubMed  Google Scholar 

  12. Turner BJ, Newschaffer CJ, Zhang D, et al.: Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV-infected women. Med Care 2000, 38:911–925.

    Article  PubMed  CAS  Google Scholar 

  13. Laine C, Newschaffer CJ, Zhang D, et al.: Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: a pharmacy claims-based analysis. Obstet Gynecol 2000, 95:167–173.

    Article  PubMed  CAS  Google Scholar 

  14. Gross R, Zhang Y, Grossberg R: Medication refill logistics and refill adherence in HIV. Pharmacoepidemiol Drug Saf 2005, 14:789–793.

    Article  PubMed  CAS  Google Scholar 

  15. Braitstein P, Justice A, Bangsberg DR, et al.: Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort. AIDS 2006, 20:323–331.

    Article  PubMed  Google Scholar 

  16. Braithwaite RS, Kozal MJ, Chang CC, et al.: Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies. AIDS 2007, 21:1579–1589.

    Article  PubMed  CAS  Google Scholar 

  17. Gross R, Yip B, Lo Re V 3rd, et al.: A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. J Infect Dis 2006, 194:1108–1114.

    Article  PubMed  Google Scholar 

  18. Gardner EM, Burman WJ, Maravi ME, Davidson AJ: Durability of adherence to antiretroviral therapy on initial and subsequent regimens. AIDS Patient Care STDS 2006, 20:628–636.

    Article  PubMed  Google Scholar 

  19. Nachega JB, Hislop M, Dowdy DW, et al.: Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr 2006, 43:78–84.

    Article  PubMed  Google Scholar 

  20. Nachega JB, Hislop M, Dowdy DW, et al.: Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med 2007, 146:564–573.

    PubMed  Google Scholar 

  21. Bisson G, Robertson A, Weinstein R: Medication refill cards predict virologic failure in Botswana [abstract TUPE0156]. Presented at the XVI International AIDS Conference. Toronto, Canada; August 13–18, 2006.

  22. Graham J, Bennett IM, Holmes WC, Gross R: Medication beliefs as mediators of the health literacy-antiretroviral adherence relationship in HIV-infected individuals. AIDS Behav 2007, 11:385–392.

    Article  PubMed  Google Scholar 

  23. Acri T, Grossberg R, Gross R: Shorter duration pharmacy refill adherence and relation to viral load. Presented at the 2006 NIMH/IAPAC International Conference on HIV Treatment Adherence. Jersey City, NJ; March 2006.

Download references

Author information

Authors and Affiliations

  1. Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, 804 Blockley Hall, 423 Guardian Drive, Philadelphia, PA, 19104-6021, USA

    Robert Grossberg

Authors
  1. Robert Grossberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert Gross
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert Grossberg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grossberg, R., Gross, R. Use of pharmacy refill data as a measure of antiretroviral adherence. Curr HIV/AIDS Rep 4, 187–191 (2007). https://doi.org/10.1007/s11904-007-0027-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11904-007-0027-4

Keywords

Search

Navigation